Alcarb 150mg Injection
Marketer
Axiommax Oncology Pvt Ltd
Salt Composition
Carboplatin (150mg)
Overview Alcarb 150mg Injection
Carbosin 150mg Injection treats ovarian and small-cell lung cancers by inhibiting cancerous cell proliferation. Administered intravenously under medical supervision, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to prescribed usage; incorrect administration or overdosage can lead to severe adverse effects. Therapeutic benefits might not be apparent for weeks or months; discontinue only under medical guidance. Common side effects include nausea, vomiting, tiredness, and elevated liver enzymes. This medication can reduce blood cell counts, potentially increasing infection or bleeding risk. Report fever, sore throat, chills, unusual bleeding or bruising, or dark urine immediately. Regular blood tests monitoring blood cell counts, liver function, heart health, and uric acid levels are necessary. Report any allergic reactions like rash, itching, or breathing difficulties. Inform your healthcare provider of all medications you are taking, as interactions are possible. This injection is contraindicated during pregnancy and breastfeeding; reliable contraception is essential for both partners throughout treatment.
Primary Ingredients of Alcarb 150mg Injection
The provided text is "undefined," which offers no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Alcarb 150mg Injection
Cancers of the ovary and small-cell lung
Major Benefits of Alcarb 150mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Alcarb 150mg Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Alcarb 150mg Injection:
Administering this medication requires a healthcare professional; your doctor or nurse will provide it. Self-medication is not advised.
How Alcarb 150mg Injection works:
OncoBloc 150mg injection is a cancer treatment that disrupts the genetic machinery (DNA and RNA) within cancerous cells, thereby halting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Alcarb 150mg Injection may pose safety risks; seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Alcarb 150mg Injection during pregnancy poses a confirmed risk to the fetus. Therefore, its use is contraindicated. Nevertheless, in exceptional, life-threatening circumstances, a physician might deem the potential benefits outweigh the risks and prescribe it. Physician consultation is mandatory.
Breast feedingUNSAFE
Administering Alcarb 150mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Alcarb 150mg Injection can induce drowsiness, visual disturbances, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCAUTION
Patients with kidney impairment should use Alcarb 150mg Injection cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Alcarb 150mg Injection. Physician consultation is essential. Regular kidney function assessments may be necessary during treatment.
LiverSAFE IF PRESCRIBED
The use of Alcarb 150mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Alcarb 150mg Injection :
Omitting a scheduled dose of Alcarb 150mg Injection necessitates contacting your physician.
Facts to Know About Alcarb 150mg Injection
| Label | Value |
|---|---|
| Pharmacological Category | Platinum-based compounds |
| Potential for Dependence | None. |
| Type of Medication | Cancer-fighting drugs |
| Mechanism of Action | Platinum-based antitumor agents |
3,018 People bought this recently